Ark Invest executed a major portfolio rebalancing, increasing exposure to Meta and Eli Lilly while trimming positions in several other stocks.
1 report, 1 independent
Updated Jul 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ark Invest executed a major portfolio rebalancing, increasing exposure to Meta and Eli Lilly while trimming positions in several other stocks.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Ark Invest, led by Cathie Wood, is buying shares of Meta ahead of its earnings report.Sub-event
Ark Invest shifts strategy, adding Meta for AI and increasing healthcare exposure via Eli Lilly.1 source
Keep exploring
The entities involved
-
Ark Invest
American asset management firm
-
Meta
American technology company
-
Eli Lilly and Company
American pharmaceutical company